Ursodeoxycholic acid protects neonatal rats from necrotizing enterocolitis: A biochemical, histopathological, and immunohistochemical study      
Yazarlar (4)
Ergün Sönmezgöz
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Şahin Takcı
Türkiye
Prof. Dr. Ali GÜL Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Murat Uysal
Kapadokya Üniversitesi, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Journal of Maternal-Fetal Neonatal Medicine
Dergi ISSN 1476-7058 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 09-2021
Cilt No 34
Sayı 22
Sayfalar 3761 / 3767
DOI Numarası 10.1080/14767058.2020.1818210
Makale Linki https://www.tandfonline.com/doi/pdf/10.1080/14767058.2020.1818210
Özet
The pathophysiology of necrotizing enterocolitis (NEC) includes the massive production of endogenous cytokines with exaggerated activation of inflammatory pathways. Ursodeoxycholic acid (UDCA) has been used as an anti-inflammatory, antioxidant, and anti-apoptotic agent. We investigated the possible protective effects of UDCA in a neonatal rat pup model of NEC. We randomly divided rat pups into three groups: a control group, a non-treated NEC group, and a UDCA-treated NEC group. We induced NEC by feeding formula enterally and hypoxia/reoxygenation. Intestinal samples were collected for histopathological and immunohistochemical evaluation. Blood samples were taken for biochemical analyses. UDCA significantly reduced the extents of terminal ileal and jejunal injuries compared to the NEC group ( < .01), reduced Bax and caspase-3 immunoreactivities (both  < .01), and lowered serum levels of platelet-activating factor and intestinal fatty acid-binding protein ( < .01,  = .023, respectively). In a rat model of NEC, UDCA protects against adverse intestinal histological, immunohistochemical, and biochemical changes. UDCA significantly reduces the effects of NEC on the rat pup intestine.
Anahtar Kelimeler
Necrotizing enterocolitis | ursodeoxycholic acid | PAF | IFABP